Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.

Standard

Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. / Goto, T; Takano, M; Albergaria, A; Briese, Juliane; Pomeranz, K M; Cloke, B; Fusi, L; Feroze-Zaidi, F; Maywald, N; Sajin, M; Dina, R E; Ishihara, O; Takeda, S; Lam, E W-F; Bamberger, Ana Maria; Ghaem-Maghami, S; Brosens, J J.

In: ONCOGENE, Vol. 27, No. 1, 1, 2008, p. 9-19.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Goto, T, Takano, M, Albergaria, A, Briese, J, Pomeranz, KM, Cloke, B, Fusi, L, Feroze-Zaidi, F, Maywald, N, Sajin, M, Dina, RE, Ishihara, O, Takeda, S, Lam, EW-F, Bamberger, AM, Ghaem-Maghami, S & Brosens, JJ 2008, 'Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.', ONCOGENE, vol. 27, no. 1, 1, pp. 9-19. <http://www.ncbi.nlm.nih.gov/pubmed/17599040?dopt=Citation>

APA

Goto, T., Takano, M., Albergaria, A., Briese, J., Pomeranz, K. M., Cloke, B., Fusi, L., Feroze-Zaidi, F., Maywald, N., Sajin, M., Dina, R. E., Ishihara, O., Takeda, S., Lam, E. W-F., Bamberger, A. M., Ghaem-Maghami, S., & Brosens, J. J. (2008). Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. ONCOGENE, 27(1), 9-19. [1]. http://www.ncbi.nlm.nih.gov/pubmed/17599040?dopt=Citation

Vancouver

Goto T, Takano M, Albergaria A, Briese J, Pomeranz KM, Cloke B et al. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells. ONCOGENE. 2008;27(1):9-19. 1.

Bibtex

@article{f1439b8da9c843458aee560bf13354f3,
title = "Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.",
abstract = "The forkhead transcription factor FOXO1, a downstream target of phosphatidylinositol-3-kinase/Akt signalling pathway, regulates cyclic differentiation and apoptosis in normal endometrium, but its role in endometrial carcinogenesis is unknown. Screening of endometrial cancer cell lines demonstrated that FOXO1 is expressed in HEC-1B cells, but not in Ishikawa cells, which in turn highly express the FOXO1 targeting E3-ubiquitin ligase Skp2. FOXO1 transcript levels were also lower in Ishikawa cells and treatment with the proteasomal inhibitor was insufficient to restore expression. Lack of FOXO1 expression in Ishikawa cells was not accounted for by differential promoter methylation or activity, but correlated with increased messenger RNA (mRNA) turnover. Comparative analysis demonstrated that HEC-1B cells proliferate slower, but are more resistant to paclitaxel-mediated cell death than Ishikawa cells, which were partially reversed upon silencing of FOXO1 in HEC-1B cells or its re-expression in Ishikawa cells. We further show that FOXO1 is required for the expression of the growth arrest- and DNA-damage-inducible gene GADD45alpha. Analysis of biopsy samples demonstrated a marked loss of FOXO1 and GADD45alpha mRNA and protein expression in endometrioid endometrial cancer compared to normal endometrium. Together, these observations suggest that loss of FOXO1 perturbs endometrial homeostasis, promotes uncontrolled cell proliferation and increases susceptibility to genotoxic insults.",
author = "T Goto and M Takano and A Albergaria and Juliane Briese and Pomeranz, {K M} and B Cloke and L Fusi and F Feroze-Zaidi and N Maywald and M Sajin and Dina, {R E} and O Ishihara and S Takeda and Lam, {E W-F} and Bamberger, {Ana Maria} and S Ghaem-Maghami and Brosens, {J J}",
year = "2008",
language = "Deutsch",
volume = "27",
pages = "9--19",
journal = "ONCOGENE",
issn = "0950-9232",
publisher = "NATURE PUBLISHING GROUP",
number = "1",

}

RIS

TY - JOUR

T1 - Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.

AU - Goto, T

AU - Takano, M

AU - Albergaria, A

AU - Briese, Juliane

AU - Pomeranz, K M

AU - Cloke, B

AU - Fusi, L

AU - Feroze-Zaidi, F

AU - Maywald, N

AU - Sajin, M

AU - Dina, R E

AU - Ishihara, O

AU - Takeda, S

AU - Lam, E W-F

AU - Bamberger, Ana Maria

AU - Ghaem-Maghami, S

AU - Brosens, J J

PY - 2008

Y1 - 2008

N2 - The forkhead transcription factor FOXO1, a downstream target of phosphatidylinositol-3-kinase/Akt signalling pathway, regulates cyclic differentiation and apoptosis in normal endometrium, but its role in endometrial carcinogenesis is unknown. Screening of endometrial cancer cell lines demonstrated that FOXO1 is expressed in HEC-1B cells, but not in Ishikawa cells, which in turn highly express the FOXO1 targeting E3-ubiquitin ligase Skp2. FOXO1 transcript levels were also lower in Ishikawa cells and treatment with the proteasomal inhibitor was insufficient to restore expression. Lack of FOXO1 expression in Ishikawa cells was not accounted for by differential promoter methylation or activity, but correlated with increased messenger RNA (mRNA) turnover. Comparative analysis demonstrated that HEC-1B cells proliferate slower, but are more resistant to paclitaxel-mediated cell death than Ishikawa cells, which were partially reversed upon silencing of FOXO1 in HEC-1B cells or its re-expression in Ishikawa cells. We further show that FOXO1 is required for the expression of the growth arrest- and DNA-damage-inducible gene GADD45alpha. Analysis of biopsy samples demonstrated a marked loss of FOXO1 and GADD45alpha mRNA and protein expression in endometrioid endometrial cancer compared to normal endometrium. Together, these observations suggest that loss of FOXO1 perturbs endometrial homeostasis, promotes uncontrolled cell proliferation and increases susceptibility to genotoxic insults.

AB - The forkhead transcription factor FOXO1, a downstream target of phosphatidylinositol-3-kinase/Akt signalling pathway, regulates cyclic differentiation and apoptosis in normal endometrium, but its role in endometrial carcinogenesis is unknown. Screening of endometrial cancer cell lines demonstrated that FOXO1 is expressed in HEC-1B cells, but not in Ishikawa cells, which in turn highly express the FOXO1 targeting E3-ubiquitin ligase Skp2. FOXO1 transcript levels were also lower in Ishikawa cells and treatment with the proteasomal inhibitor was insufficient to restore expression. Lack of FOXO1 expression in Ishikawa cells was not accounted for by differential promoter methylation or activity, but correlated with increased messenger RNA (mRNA) turnover. Comparative analysis demonstrated that HEC-1B cells proliferate slower, but are more resistant to paclitaxel-mediated cell death than Ishikawa cells, which were partially reversed upon silencing of FOXO1 in HEC-1B cells or its re-expression in Ishikawa cells. We further show that FOXO1 is required for the expression of the growth arrest- and DNA-damage-inducible gene GADD45alpha. Analysis of biopsy samples demonstrated a marked loss of FOXO1 and GADD45alpha mRNA and protein expression in endometrioid endometrial cancer compared to normal endometrium. Together, these observations suggest that loss of FOXO1 perturbs endometrial homeostasis, promotes uncontrolled cell proliferation and increases susceptibility to genotoxic insults.

M3 - SCORING: Zeitschriftenaufsatz

VL - 27

SP - 9

EP - 19

JO - ONCOGENE

JF - ONCOGENE

SN - 0950-9232

IS - 1

M1 - 1

ER -